Two such biomarkers, TMB and PD-L1 expression, appear to be less relevant in the paediatric setting than in adult cancers, with the exception of rare hypermutated tumours harbouring a DNA mismatch repair deficiency or polymerase proofreading deficiency. This evidence concerns the gene CD274 and cancer.